Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease
暂无分享,去创建一个
B. Flourié | L. Peyrin-Biroulet | X. Roblin | G. Boschetti | G. Duru | N. Williet | J. Phelip | S. Nancey | É. Del Tedesco | M. Cuilleron | S. Paul | C. Jarlot